1 May 1992

Thrombosis in Antithrombin-III-deficient Persons: Report of a Large Kindred and Literature Review

Publication: Annals of Internal Medicine
Volume 116, Number 9


Purpose: To estimate the prevalence of objectively proven thrombotic complications in antithrombin-III-deficient persons.
Study Design: Cross-sectional study and a critical review of the literature.
Data Sources and Extraction: The prevalence of thrombosis in antithrombin III-deficient and -nondeficient family members of a large kindred was estimated by history, review of diagnostic tests, and examination for venous reflux by Doppler ultrasonography, as an indicator of previous venous thrombosis.
A MEDLINE search and literature review of the published English- and French-language literature from 1966 to 1990 that described antithrombin-III-deficient families was done, and the following information was obtained: the prevalence of thrombosis in deficient and nondeficient family members, the presence or absence of risk factors for thrombosis (surgery, pregnancy, the postpartum state, use of oral contraceptives, immobiization, metastatic cancer, major trauma) at the time of the thrombotic event, and age of onset of the first episode of thrombosis. The validity of the studies was assessed according to predetermined criteria.
Results: Sixty-seven research subjects were evaluated. Six of 31 (19.4%) antithrombin-III-deficient subjects compared with none of 36 (0%) nondeficient subjects had had one or more thrombotic events. The initial episode in five of six subjects had occurred in association with risk factors for thrombosis.
The literature search indicated that the pooled prevalence of symptomatic venous thrombosis among the deficient subjects was 51%, but objective testing was done in only 17% of these subjects at the time of presentation.
Conclusion: Based on the data from this antithrombin-III-deficient kindred, lifelong anticoagulant prophylaxis does not appear to be warranted in asymptomatic carriers, and prophylaxis could be limited to periods of high risk for thrombosis.

Get full access to this article

View all available purchase options and get full access to this article.


Thaler E and Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 1981;10:369-90.
Barnes RWu K, and Hoak J. Fallibility of the clinical diagnosis of venous thrombosis. JAMA. 1975;234:605-7.
Devraj-Kizuk RChui DProchownik ECarter COfosu F, and Blajchman M. Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity. Blood. 1988;72:1518-23.
Ginsberg JShin ATurpie A, and Hirsh J. Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography. Arch Intern Med. 1989;149:2255-7.
Kahle LSchipper HJenkins C, and ten Cate J. Antithrombin III. I. Evaluation of an automated antithrombin III method. Thromb Res. 1978;12:1003-14.
Fernandez-Rachubinski F and Blajchman M. A useful restriction analysis for the determination of antithrombin III variants with mutation from Ala 382 to Ala 384. Thromb Res. [In press].
Mendelsohn GGomperts E, and Gurwitz D. Severe antithrombin III deficiency in an infant associated with multiple arterial and venous thromboses. Thromb Haemost. 1976;36:495-502.
Owen MBorg JSoria CSoria JCaen J, and Carrell R. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. Blood. 1987;69:1275-9.
Borg JOwen MSoria CSoria JCaen J, and Carrell R. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser. J Clin Invest. 1988;81:1292-6.
Fisher AGazengel CDautzenberg MBenhammo JBeguin S, and Vergoz D. A new case of abnormal antithrombin III (AT III): biological characteristics and thromboembolic accidents management [Abstract]. Thromb Haemost. 1983;50:358.
Fisher ACornu PSternberg CMeriane FDautzenberg M, and Chafa O. Antithrombin III Alger: a new homozygous AT III variant. Thromb Haemost. 1986;55:218-21.
Wolf MBoyer-Neumann CMolho-Sabatier PNeumann CMeyer D, and Larrieu M. Familial variant of antithrombin III (AT III Bligny, 47 Arg to His) associated with protein C deficiency. Thromb Haemost. 1990;63:215-9.
Boyer CWolf MVedrenne JMeyer D, and Larrieu M. Homozygous variant of antithrombin III: AT III Fontainebleau. Thromb Haemost. 1986;56:18-22.
de Moerloose PReber GVernet PMinazio P, and Bouvier C. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity. Thromb Haemost. 1987;57:154-7.
Okajima KUeyama HHashimoto YSasaki YMatsumoto K, and Okabe H. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto. Thromb Haemost. 1989;61:20-4.
Girolami AFabris FCappellato GSainati L, and Boeri G. Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease. Blut. 1983;47:93-103.
Wolf MBoyer CLavergne J, and Larrieu M. A new familial variant of antithrombin III: antithrombin III Paris. Br J Haematol. 1982;51:285-95.
Sakuragawa NTakahashi KKondo S, and Koide T. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis. Thromb Res. 1983;31:305-17.
Duchange NChasse JCohen G, and Zakin M. Molecular characterization of the antithrombin III Tours deficiency. Thromb Res. 1987;45:115-21.
Tran TBounameaux HBondeli CHonkamen HMarbet G, and Duckert F. Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis. Thromb Haemost. 1980;44:87-91.
Roussel BDieval JDelobel JFernandez-Rachubinski FEng B, and Rachubinski R. Antithrombin-III-Amiens: a new family with an Arg47—Cys inherited variant of antithrombin III with impaired heparin cofactor activity. Am J Hematol. 1991;36:25-9.
Aiach MFrancois DPriollet PCapron LRoncato M, and Alhenc-Gelas M. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy. Br J Haematol. 1987;66:515-22.
Girolami APengo VCappellato GVianello CProcidano M, and Cartei C. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease. Folia Haematol (Leipz). 1983;110:98-111.
Daly MBall RO'Meara A, and Hallinan F. Identification and characterisation of an antithrombin III mutant (AT Dublin 2) with marginally decreased heparin reactivity. Thromb Res. 1989;56:503-13.
Matsuo TOhki YKondo S, and Matsuo O. Familial antithrombin III deficiency in a Japanese family. Thromb Res. 1979;16:815-23.
Gyde OMiddleton MVaughan G, and Fletcher D. Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses. BMJ. 1978;1:621-2.
Leone GValori VStorti S, and Myers T. Inferior vena cava thrombosis in a child with familial antithrombin III deficiency [Letter]. Thromb Haemost. 1980;43:74.
Boyer CWolf MLavergne J, and Larrieu M. Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency. Thromb Res. 1980;20:207-18.
Pitney WManoharan A, and Dean S. Antithrombin III deficiency in an Australian family. Br J Haematol. 1980;46:147-9.
Meer JvStoepman-van Dalen E, and Jansen J. Antithrombine deficiency in a Dutch family. J Clin Pathol. 1973;26:532-8.
Marciniak EFarley C, and DeSimone P. Familial thrombosis due to antithrombin 3 deficiency. Blood. 1974;43:219-31.
Winter JFenech ARidley WBennett BCumming A, and Mackie M. Familial antithrombin III deficiency. Q J Med. 1982;51:373-95.
Rey JDelobel JClaisse JQuiret JBor P, and Bernasconi P. Embolie pulmonaire sévère et thrombophlébite récidivante en rapport avec un déficit hériditaire en antithrombine III. Arch Mal Coeur Vaiss. 1979;72:919-23.
Juillet YVayssairat MFiessinger JAiach M, and Housset E. Thrombose des veines porte et mésenterique supérieure au cours d'un déficit congénital et familial en antithrombine III. Ann Med Interne (Paris). 1979;130:53-7.
Hofman KGoldman ALurie MHockly J, and Bradlow B. Familial thrombosis associated with antithrombin III deficiency in a young adult male. S Afr Med J. 1980;58:531-3.
Ambruso DJacobson L, and Hathaway W. Inherited antithrombin III deficiency and cerebral thrombosis in a child. Pediatrics. 1980;65:125-31.
Tripodi ABoyer CCanciani MD'Angelo A, and Mannucci P. Inherited deficiency of antithrombin III in an Italian kindred. Ric Clin Lab. 1980;10:521-9.
Johansson LHedner U, and Nilsson I. Familial antithrombin III deficiency as pathogenesis of deep venous thrombosis. Acta Med Scand. 1978;204:491-5.
Carvalho A and Ellman L. Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function. Am J Med. 1976;61:179-83.
Thuot CMarion D, and Boucher H. Déficit congenital en antithrombine III: etude d'une famille québécoise. Union Med Can. 1977;106: 673-7.
Cosgriff TBishop DHershgold ESkolnick MMartin B, and Baty B. Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment. Medicine (Baltimore). 1983;62:209-20.
Scully MDe Haas HChan P, and Kakkar W. Hereditary antithrombin III deficiency in an English family. Br J Haematol. 1981;47:235-40.
Beukes C and Heyns A. A South African family with antithrombin III deficiency. S Afr Med J. 1980;58:528-30.
Brenner BFishman AGoldsher DSchreibman D, and Tavory S. Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol. 1988;27:209-11.
Griffith MCarraway TWhite G, and Dombrose F. Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma. Blood. 1983;61:111-8.
Manotti CQuintavalla RMegha APonari O, and Dettori A. Inherited deficiency of antithrombin III in two Italian families. Haemostasis. 1982;12:300-8.
Stathakis NPapayannis AAntonopoulos M, and Gardikas C. Familial thrombosis due to antithrombin III deficiency in a Greek family. Acta Haematol. 1977;57:47-54.
Odegard O and Abildgaard U. Antifactor Xa activity in thrombophilia. Studies in a family with Ar-III deficiency. Scand J Haematol. 1977; 18:86-90.
Maramatsu SMizuno YMurayama H, and Ikemoto S. Hereditary antithrombin III deficiency with a superior sagittal sinus thrombosis: evidence for a possible mutation starting in the mother of the propositus. Thromb Res. 1990;57:593-600.
Phifer T and Mills G. Occult antithrombin III deficiency: a potentially lethal complication of the postphlebitic limb. J Vasc Surg. 1990;11:586-90.
Concannon A and Low J. Antithrombin III deficiency in a Chinese family. Med J Aust. 1981;1:521-3.
Chamontin BGuittard JLaroche MBoneu B, and Salvador M. Traitement d'une thrombose veineuse profonde en présence d'un déficit congenital en antithrombine III. A propos de l'utilisation de concentrés purifiés. Arch Mal Coeur Vaiss. 1984;77:1064-7.
Candrina RCoppini ASalvi AZuccato FDel Bono R, and Giustina G. Inherited antithrombin III deficiency in an Italian family, associated with venous and arterial thrombosis. Haematologica. 1985;70:399-404.
Girolami ACappellato MVicarioto MMarafiotti FTraverso R, and Vergolani A. Antithrombin III deficiency: a report of 14 cases belonging to three different kindreds. Folia Haematol (Leipz). 1985; 112:594-606.
d'Souza S and Ekert H. Familial deficiency of antithrombin III: evidence for heterogeneity existing within the family. Aust N Z J Med. 1984;14:835-40.
Lee MChang YPark SPark MKim B, and Han Y. Hereditary antithrombin III deficiency in a Korean family. Acta Haematol Jpn. 1986;49:980-6.
Zucker MGomperts E, and Marcus R. Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency. S Afr Med J. 1976;50:1743-8.
Leone GCotumaccio RDe Stefano V, and Zanetti L. Antithrombin III Roma: a familial quantitative-qualitative AT-III deficiency identifiable by crossed immunoelectrofocusing and by crossed immunoelectrophoresis. Haematologica. 1983;68:765-74.
Sas GPeto IBanhegyi DBlasko G, and Domjan G. Heterogeneity of the "classical" antithrombin III deficiency. Thromb Haemost. 1980; 43:133-6.
Grau EFontcuberta JFelez Jde Diego ISoto R, and Rutllant M. AT III Barcelona: a familial quantitative-qualitative AT III deficiency. Thromb Haemost. 1988;59:13-7.
Fontcuberta JGrau ERubio NFelez J, and Rutilant M. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2. Thromb Res. 1988;51:75-81.
Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diathesis Haemorrh. 1965;13:516-30.
Johnson EPrentice C, and Parapia L. Premature arterial disease associated with familial antithrombin III deficiency. Thromb Haemost. 1990;63:13-5.
Aiach MNora MFiessinger JRoncoto MFrancois D, and Gelas M. A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville. Thromb Res. 1985;39:559-70.
Sambrano JJacobson LReeve EManco-Johnson M, and Hathaway W. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver"). J Clin Invest. 1986;77:887-93.
Wolf MBoyer CTripodi AMeyer DLarrieu M, and Mannucci P. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III. Blood. 1985;65:496-500.
Tripodi AKrachmalnicoff A, and Mannucci P. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding. Thromb Haemost. 1986;56:349-52.
Leone GDe Stefano VDi Donfrancesco AFerrelli RTraisci G, and Bizzi B. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed Immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern. Br J Haematol. 1987;65:187-91.
Girolami AMarafioti FRubertelli MVicarioto MCappellato G, and Mazzuccato M. Antithrombin III Trento. A "new" congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin. Acta Haematol. 1984;72:73-82.
Barbui TFinazzi GRodeghiero F, and Dini E. Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III "Vicenza"). Br J Haematol. 1983;54:561-5.
Bauer KAshenhurst JChediak J, and Rosenberg R. Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia. Blood. 1983;62:1242-50.
Lane DLowe GFlynn AThompson EIreland H, and Erdjument H. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. Br J Haematol. 1987;66:523-7.
Lane DErdjument HFlynn ADi Marzo VPanico M, and Morris H. Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis. Br J Haematol. 1989;71:91-6.
Howarth DSamson DStirling Y, and Seghatchian M. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity. Thromb Haemost. 1985;53:314-9.
Bessot JQuoix ECharbonneau JBurghard GWiessel M, and Kalogjera N. Déficit hériditaire en anti-thrombine III responsable d'accidents thrombo-emboliques récidivants. Nouv Presse Med. 1978;7:999-1002.
Pewarchuk WFernandez-Rachubinski FRachubinski R, and Blajchman M. Antithrombin III Sudbury: an Ala384—Pro mutation with abnormal thrombin-binding activity and thrombotic diathesis. Thromb Res. 1990;59:793-7.
Aiach MRoncato MChadeuf GDezellus PCapron L, and Fiessenger J. Antithrombin III Avranches, a new variant with defective serine-protease inhibition—comparison with antithrombin III Charleville. Thromb Haemost. 1988;60:94-6.
Tengborn LFrohm BNilsson L, and Nilsson I. A Swedish family with abnormal antithrombin III. Scand J Haematol. 1985;34:412-6.
Perry DHarper PFairham SDaly M, and Carrell R. Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reaction. FEBS Lett. 1989;254:174-6.
Sorensen PDyerberg JStoffersen E, and Jensen M. Familial functional antithrombin III deficiency. Scand J Haematol. 1980;24:105-9.
Hull RRaskob GLeClerc JJay R, and Hirsh J. The diagnosis of clinically suspected venous thrombosis. Clin Chest Med. 1984;5: 439-56.
Rosendaal FHeijboer HBriet EBuller HBrandjes D, and de Bruin K. Mortality in hereditary antithrombin-III deficiency—1830-1989. Lancet. 1991;337:260-2.

Information & Authors


Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 116Number 91 May 1992
Pages: 754 - 761


Published in issue: 1 May 1992
Published online: 1 December 2008




Jeffrey S. Ginsberg, MD
Morris A. Blajchman, MD
From McMaster University and the Canadian Red Cross Society, Hamilton, Ontario, Canada. For current author addresses, see end of text.

Metrics & Citations



If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.


Download article citation data for:
Christine Demers, Jeffrey S. Ginsberg, Jack Hirsh, et al. Thrombosis in Antithrombin-III-deficient Persons: Report of a Large Kindred and Literature Review. Ann Intern Med.1992;116:754-761. doi:10.7326/0003-4819-116-9-754

View More

Get Access

Login Options:

You will be redirected to to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to to create an account that will provide access to Annals.

View options


View PDF/ePub

Related in ACP Journals







Copy the content Link

Share on social media